lung adenocarcinoma

You have access
A novel recurrence-associated metabolic prognostic model for risk stratification and therapeutic response prediction in patients with stage I lung adenocarcinoma
Chengming Liu, Sihui Wang, Sufei Zheng, Xinfeng Wang, Jianbin Huang, Yuanyuan Lei, Shuangshuang Mao, Xiaoli Feng, Nan Sun and Jie He

Cancer Biology & Medicine August 2021, 18 (3) 734-749; DOI: https://doi.org/10.20892/j.issn.2095-3941.2020.0397
You have access
A nomogram-based immune-serum scoring system predicts overall survival in patients with lung adenocarcinoma
Qiujuan Huang, Tongyuan Qu, Lisha Qi, Changxu Liu, Yuhong Guo, Qianru Guo, Guangning Li, Yalei Wang, Wenshuai Zhang, Wei Zhao, Danyang Ren, Leina Sun, Shengguang Wang, Bin Meng, Baocun Sun, Bin Zhang, Wenjuan Ma and Wenfeng Cao

Cancer Biology & Medicine May 2021, 18 (2) 517-529; DOI: https://doi.org/10.20892/j.issn.2095-3941.2020.0648
You have access
Anlotinib suppresses lymphangiogenesis and lymphatic metastasis in lung adenocarcinoma through a process potentially involving VEGFR-3 signaling
Tingting Qin, Zhujun Liu, Jing Wang, Junling Xia, Shaochuan Liu, Yanan Jia, Hailin Liu and Kai Li

Cancer Biology & Medicine August 2020, 17 (3) 753-767; DOI: https://doi.org/10.20892/j.issn.2095-3941.2020.0024
You have access
The correlation and overlaps between PD-L1 expression and classical genomic aberrations in Chinese lung adenocarcinoma patients: a single center case series
Jianghua Wu, Wei Sun, Haiyue Wang, Xiaozheng Huang, Xinyu Wang, Weiyang Jiang, Ling Jia, Ping Wang, Qin Feng and Dongmei Lin

Cancer Biology & Medicine November 2019, 16 (4) 811-821; DOI: https://doi.org/10.20892/j.issn.2095-3941.2019.0209

Main menu

User menu

Search

lung adenocarcinoma

Navigate

More Information

For Authors

Journal Services